Insurancenewsnet.com

Results From Phase 3 FRAME Study Of Romosozumab Showed Significant Reductions In Both New Vertebral And Clinical Fractures In Postmenopausal Women With Osteoporosis

THOUSAND OAKS, Calif. and BRUSSELS, Sept. 18, 2016/ PRNewswire/-- Amgen and UCB today announced findings from the FRAME study showing that the investigational agent romosozumab significantly reduced ...
Reuters

Inception Research Institute and Frame Partner on Study to Improve Fertility Patient Retention and Reduce Emotional Stress

HOUSTON, TX, July 11, 2025 (EZ Newswire) -- Inception Research Institute, opens new tab, part of Inception Fertility, opens new tab (Inception), today announced a new partnership with Frame, opens new ...
Yahoo Finance

Verastem Oncology Announces Nature Medicine Publication of the Results from the First-in-Human Phase 1 FRAME Study of Avutometinib in Combination with Defactinib in Solid ...

FRAME study demonstrated a 42.3% ORR and 20.1 months median PFS for all patients with low-grade serous ovarian cancer (LGSOC), regardless of KRAS mutation; for patients with KRAS-mutated LGSOC, ORR ...